Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

High-Dose Intravenous Immunoglobulin and Immunosuppressive Therapy Have Therapeutic Potential for Non-Infectious Myelopathy and Peripheral Neuropathy Following Cord Blood Transplantation

Michiho Ebihara, MD, Shinsuke Takagi, Yoshikazu Uesaka, MD PhD, Takashi Mitsuki, MD, Mitsuhiro Yuasa, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Yuki Taya, MD PhD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Yukako Koike, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Atsushi Wake, MD PhD, Naoyuki Uchida, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2018) 132 (Supplement 1): 3390.

https://doi.org/10.1182/blood-2018-99-116308

Published: 2018

Journal Articles

Mass Spectrometry to Measure Response in Immunoglobulin Light Chain Amyloidosis (AL)

Blood (2018) 132 (Supplement 1): 4502.

https://doi.org/10.1182/blood-2018-99-119969

Published: 2018

Journal Articles

Prevalence of Oligoclonal Bands in Multiple Myeloma Patients Who Achieved Better Results Than Very Good Partial Response after Treatment with Standard or High Doses Chemotherapy-Final Analysis

Luiza soares Vieira, MD, Edvan de queiroz Crusoe, MD MsC, Manuella de S. Sampaio Almeida, MD PhD, Lais Sousa, MD, ana Lucia Perez, MD, Priscilla Cury, MD, Marina Rossato, MD, Fabiana Higashi, MD, ana Luiza Dias, MD, anna Carolina Castro, MD, Carlos Chiattone, MD PhD, Vania T M Hungria, MDPhD

Blood (2015) 126 (23): 4210.

https://doi.org/10.1182/blood.V126.23.4210.4210

Published: 2015

Journal Articles

Long-Term Survivors after Stem Cell Transplantation in Multiple Myeloma: Bone Marrow Minimal Residual Disease, PET/CT and Immunological Status

Carlos Fernández de Larrea, Xavier Calvo, Natalia Tovar, Ester Lozano, Xavier Setoain, Manel Juan, Tania Díaz, Laura Rosiñol, Montserrat Elena, Mª Teresa Cibeira, Ignacio Isola, Maria Rozman, Juan I. Aróstegui, Jordi Yagüe, Joan Bladé, MD

Blood (2015) 126 (23): 4192.

https://doi.org/10.1182/blood.V126.23.4192.4192

Published: 2015

Journal Articles

Prognostic Implications of Oligoclonal Bands in Patients with Multiple Myeloma:Its Development per Se did Not Confer the Prologation of Survival

Manabu Fujisawa, MD, Yasuhito Suehara, MD, Keisuke Seike, MD, Kota Fukumoto, MD, Masafumi Fukaya, MD, Hiroki Sugihara, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2014) 124 (21): 4721.

https://doi.org/10.1182/blood.V124.21.4721.4721

Published: 2014

Journal Articles

Guilain-Barre’ Syndrome (GBS) Post Adult Cord Blood Transplantation In a Patient With Chronic Lymphocytic Leukemia (CLL)

Melhem M. Solh, MD, Tori Smith, Jason Balls, Megan Smith, Yasser Khaled, MD

Blood (2013) 122 (21): 5497.

https://doi.org/10.1182/blood.V122.21.5497.5497

Published: 2013

Journal Articles

Characterization and Prognostic Impact of Oligoclonal Humoral Response in Patients with Multiple Myeloma After Autologous Stem-Cell Transplantation: Long-Term Results From a Single Institution

Natalia Tovar, Carlos Fernández de Larrea, Juan I. Aróstegui, María Teresa Cibeira, Laura Rosiñol, MD, Montserrat Rovira, Montserrat Elena, Xavier Filella, Jordi Yagüe, Joan Blade, MD

Blood (2012) 120 (21): 3948.

https://doi.org/10.1182/blood.V120.21.3948.3948

Published: 2012

Journal Articles

Monoclonal and Oligoclonal Bands After Single Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Impact On Overall Survival and Progression-Free Survival

Victor Hugo Jimenez-Zepeda, MD, Norman Franke, MD, Andrew Winter, Sr., RN, Suzanne Trudel, MD, MSC, FRCPC, Christine I. Chen, MD, Rodger E. Tiedemann, MD, PhD FRACP FRCPA, Vishal Kukreti, MD

Blood (2012) 120 (21): 595.

https://doi.org/10.1182/blood.V120.21.595.595

Published: 2012

Journal Articles

CNS Involvement In A Patient with Waldenstrom’s Macroglobulinemia-A Diagnostic Challenge

Ambuga Badari, MBBS, James Miller, PA, Gerald L. Logue, MD, Zale P Bernstein, MD

Blood (2011) 118 (21): 4595.

https://doi.org/10.1182/blood.V118.21.4595.4595

Published: 2011

Journal Articles

Discrepancies in Serum Free Light Chain Assays and Immunofixation for Response Evaluation and Prognostication in Plasma Cell Proliferative Disorders

Nasir Bakshi, M.D., Nahlah AlGhasham, MD, Maha Alharbi, Jalaluddin Bhuiyan, Ph.D, Ghada Elgohary, MD, Fahad Alsharief, MD

Blood (2011) 118 (21): 5099.

https://doi.org/10.1182/blood.V118.21.5099.5099

Published: 2011

Journal Articles

Toward deeper response in MM

Joan Bladé, Carlos Fernández de Larrea

Blood (2011) 117 (11): 2986–2987.

https://doi.org/10.1182/blood-2011-02-332536

Published: 2011

Journal Articles

Oligoclonal Bands In Patients with Multiple Myeloma In Complete Remission After Induction Chemotherapy: Strong Association with the Use of Novel Agents

Carlos Fernández de Larrea, Natalia Tovar, María Teresa Cibeira, Juan I. Aróstegui, Laura Rosiñol, Montserrat Elena, Xavier Filella, Jordi Yagüe, Joan Blade

Blood (2010) 116 (21): 2945.

https://doi.org/10.1182/blood.V116.21.2945.2945

Published: 2010

Journal Articles

Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition

Carlos Fernández de Larrea, María Teresa Cibeira, Montserrat Elena, Juan Ignacio Arostegui, Laura Rosiñol, Montserrat Rovira, Xavier Filella, Jordi Yagüe, Joan Bladé

Blood (2009) 114 (24): 4954–4956.

https://doi.org/10.1182/blood-2009-06-224832

Published: 2009

Journal Articles

“Lymphomatous and Leukemic Meningitis – Patterns of Cytomorphology and Value of MRI and Protein Analysis”.

Herwig Matthias Strik, Christina Perske, Peter Proemmel, Ingelore Nagel, Holger Nagel

Blood (2009) 114 (22): 5011.

https://doi.org/10.1182/blood.V114.22.5011.5011

Published: 2009

Journal Articles

The Relationship Between Serum Free Light Chain Levels and Serum Immunofixation Electrophoresis: Implications for the Definition of “Stringent CR” in Myeloma

S. Allen, E. Vickrey, J. Mehta, S. Singhal

Blood (2008) 112 (11): 2724.

https://doi.org/10.1182/blood.V112.11.2724.2724

Published: 2008

Journal Articles

The Utility of Serum Free Light Chain Measurement in Myeloma Patients with Oligoclonal Bands on Serum or Urine Immunofixation

E. Vickrey, S. Allen, J. Krishnamurthy, V. Singh, J. Mehta, S. Singhal

Blood (2008) 112 (11): 5121.

https://doi.org/10.1182/blood.V112.11.5121.5121

Published: 2008

Journal Articles

Serum Free Light Chain Measurement in Myeloma Patient Samples with Oligoclonal Protein Bands.

Regina Stein, Jayesh Mehta, Eric Vickrey, William Resseguie, Seema Singhal

Blood (2006) 108 (11): 5044.

https://doi.org/10.1182/blood.V108.11.5044.5044

Published: 2006

Journal Articles

Significance of Serum Free Light Chain Estimation with Detectable Serum Monoclonal Protein on Immunofixation Electrophoresis.

Jayesh Mehta, Regina Stein, Eric Vickrey, William Resseguie, Seema Singhal

Blood (2006) 108 (11): 5048.

https://doi.org/10.1182/blood.V108.11.5048.5048

Published: 2006

Journal Articles

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

Blood (2003) 102 (7): 2364–2372.

https://doi.org/10.1182/blood-2002-12-3908

Published: 2003

Journal Articles

Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell Transplantation

C.S. Zent, C.S. Wilson, G. Tricot, S. Jagannath, D. Siegel, K.R. Desikan, N. Munshi, D. Bracy, B. Barlogie, A.W. Butch

Blood (1998) 91 (9): 3518–3523.

https://doi.org/10.1182/blood.V91.9.3518

Published: 1998

NARROW

High-Dose Intravenous Immunoglobulin and Immunosuppressive Therapy Have Therapeutic Potential for Non-Infectious Myelopathy and Peripheral Neuropathy Following Cord Blood Transplantation

Mass Spectrometry to Measure Response in Immunoglobulin Light Chain Amyloidosis (AL)

Prevalence of Oligoclonal Bands in Multiple Myeloma Patients Who Achieved Better Results Than Very Good Partial Response after Treatment with Standard or High Doses Chemotherapy-Final Analysis

Long-Term Survivors after Stem Cell Transplantation in Multiple Myeloma: Bone Marrow Minimal Residual Disease, PET/CT and Immunological Status

Prognostic Implications of Oligoclonal Bands in Patients with Multiple Myeloma:Its Development per Se did Not Confer the Prologation of Survival

Guilain-Barre’ Syndrome (GBS) Post Adult Cord Blood Transplantation In a Patient With Chronic Lymphocytic Leukemia (CLL)

Characterization and Prognostic Impact of Oligoclonal Humoral Response in Patients with Multiple Myeloma After Autologous Stem-Cell Transplantation: Long-Term Results From a Single Institution

Monoclonal and Oligoclonal Bands After Single Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Impact On Overall Survival and Progression-Free Survival

CNS Involvement In A Patient with Waldenstrom’s Macroglobulinemia-A Diagnostic Challenge

Discrepancies in Serum Free Light Chain Assays and Immunofixation for Response Evaluation and Prognostication in Plasma Cell Proliferative Disorders

Toward deeper response in MM

Oligoclonal Bands In Patients with Multiple Myeloma In Complete Remission After Induction Chemotherapy: Strong Association with the Use of Novel Agents

Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition

“Lymphomatous and Leukemic Meningitis – Patterns of Cytomorphology and Value of MRI and Protein Analysis”.

The Relationship Between Serum Free Light Chain Levels and Serum Immunofixation Electrophoresis: Implications for the Definition of “Stringent CR” in Myeloma

The Utility of Serum Free Light Chain Measurement in Myeloma Patients with Oligoclonal Bands on Serum or Urine Immunofixation

Serum Free Light Chain Measurement in Myeloma Patient Samples with Oligoclonal Protein Bands.

Significance of Serum Free Light Chain Estimation with Detectable Serum Monoclonal Protein on Immunofixation Electrophoresis.

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only